# Advanced Development of Medical Countermeasures for Infectious Diseases

> **NIH NIH N01** · NANOTHERAPEUTICS, INC. · 2021 · $4,233,500

## Abstract

To support the advanced development of a promising candidate therapeutic. The research and development activities to be supported will allow the candidate therapeutic product to progress along the product development pathway, and include preclinical and IND enabling development activities, and clinical safety and efficacy assessment.

## Key facts

- **NIH application ID:** 10360409
- **Project number:** 75N93019C00057-P00002-9999-1
- **Recipient organization:** NANOTHERAPEUTICS, INC.
- **Principal Investigator:** MILAN TOMIC
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $4,233,500
- **Award type:** —
- **Project period:** 2019-09-09 → 2022-05-21

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10360409

## Citation

> US National Institutes of Health, RePORTER application 10360409, Advanced Development of Medical Countermeasures for Infectious Diseases (75N93019C00057-P00002-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10360409. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*